Evidence map›Paper›PMID 37485480›Full record

ReviewInterventional radiology (Higashimatsuyama-shi (Japan)2023

Endovascular and Percutaneous Embolotherapy for the Body and Extremity Arteriovenous Malformations.

Keigo Osuga, Kazuhiro Yamamoto, Hiroki Higashihara, Hiroshi Juri, Kiyohito Yamamoto, Akira Higashiyama, Hiroki Matsutani, Asami Sugimoto, Sou Toda, Tomohiro Fujitani

Open access · diamondAbstract readReview
In one paragraph

Review in Interventional radiology (Higashimatsuyama-shi (Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Keigo OsugaDepartment of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Japan.
Kazuhiro YamamotoDepartment of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Japan.
Hiroki HigashiharaDepartment of Diagnostic and Interventional Radiology, Osaka University Graduate School of Medicine, Japan.
Hiroshi JuriDepartment of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Japan.
Kiyohito YamamotoDepartment of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Japan.
Akira HigashiyamaDepartment of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Japan.
Hiroki MatsutaniDepartment of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Japan.
Asami SugimotoDepartment of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Japan.
Sou TodaDepartment of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Japan.
Tomohiro FujitaniDepartment of Diagnostic Radiology, Osaka Medical and Pharmaceutical University, Japan.
Osaka University of Pharmaceutical Sciences · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arteriovenous malformations (AVMs) consist of abnormal communications between the arteries and veins. They can involve any part of the body and extremity and grow in proportion to age and in response to hormonal influence or trauma. When symptoms progress from Schöbinger clinical stage II to III, transcatheter and/or direct puncture embolization are less-invasive and repeatable options for symptom palliation. The goal of embolization is to obliterate the AV shunt, and the choice of lesion access and embolic agents is based on the individual anatomy and flow. Embolization can be technically challenging due to complex vascular anatomy and morbidity risks. Therefore, a multidisciplinary management is essential for the diagnosis and therapeutic intervention of AVMs.

Indexed as

arteriovenous fistulaarteriovenous malformationsarteriovenous shuntembolic agentsembolization

Identifiers

PMID37485480
PMCPMC10359173
OpenAlexW4379184800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.